Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to evaluate whether the timing and dosage of exogenous melatonin can improve sleep onset and maintenance in healthy adults aged 18-45 years (50% female) with no hist...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
IRCCS Fondazione Stella Maris
NCT07426991 · Multiple Sclerosis, Remitting-Relapsing Multiple Sclerosis, and more
NCT07168577 · Cerebral Palsy, Sleep Disorders in Children, and more
NCT07299578 · Sleep Disorders
NCT06941948 · Impact of Sleep Disorders on Tumor Immune Microenvironment and Clinical Outcomes in Lung Cancer
NCT06473415 · Critical Illness, Delirium, and more
University of Pisa, Institute of Physiology, Sonnolab
Pisa, PI
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions